Applied StemCell, Inc. (“ASC”), a genome engineering company with deep expertise in induced pluripotent stem cell (iPSC) technology and Cellipont Bioservices, a cell therapy contract development and ...

The standard procedure involves extracting a patient’s T cells, genetically modifying them in specialised facilities to recognise cancer cells, and reinfusing them into the bloodstream. While ...

Tissue Engineering (TE) strategies combining stem cells, biomaterial scaffolds, and biochemical/physical cues have emerged as promising approaches for the repair/replacement of injured tissues and ...

For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune cell—known as helper T cells—from stem cells in a ...

UBC research associate Dr. Ross Jones in the lab where they are working to develop cell-based therapies from stem cells. Credit: Phillip Chin. For the first time, researchers at the University of ...